Low-level monocyte chemoattractant protein-1 stimulation of monocytes leads to tumor formation in nontumorigenic melanoma cells

Journal of Immunology

Volumn 166, Issue 11, 2001, Pages 6483-6490

  Nesbit, Mark ^a   Schaider, Helmut ^a   Miller, Thomas H ^a   Herlyn, Meenhard ^a  

^a WISTAR INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE; GENE PRODUCT; MONOCYTE CHEMOTACTIC PROTEIN 1; TUMOR NECROSIS FACTOR ALPHA;

ANGIOGENESIS; ARTICLE; CARCINOGENESIS; CELL INFILTRATION; CONTROLLED STUDY; CORRELATION FUNCTION; CYTOKINE RELEASE; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; LEUKOCYTE ACTIVATION; MELANOMA; MONOCYTE; NEUTROPHIL CHEMOTAXIS; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; TUMOR CELL LINE; TUMOR VASCULARIZATION;

EID: 0035336409     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.166.11.6483     Document Type: Article

References (66)

1. Mantovani, A., B. Bottazzi, F. Colotta, S. Sozzani, and L. Ruco. 1992. The origin and function of tumor-associated macrophages. Immunol. Today 13:265.
2. Rollins, B. 1997. Chemokines. Blood 90:909.
3. Gerszten, R. E., E. A. Garcia-Zepeda, Y. C. Lim, M. Yoshida, H. A. Ding, M. A. Gimbrona, A. D. Luster, F. W. Luscinskas, and A. Rosenzweig. 1999. MCP-1 and IL-8 trigger firm adhesion of monocytes to vascular endothelium under flow conditions. Nature 398:718.
4. Strieter, R. M., S. L. Kunkel, V. M. Elner, C. L. Martonyi, A. E. Koch, P. J. Polverini, and S. G. Elner. 1992. Interleukin-8, a corneal factor that induces neovascularization. Am. J. Pathol. 141:1279.
5. Rollins, B. J., A. Walz, and M. Baggiolini. 1991. Recombinant human MCP-1/JE induces chemotaxis, calcium flux, and the respiratory burst in human monocytes. Blood 78:1112.
6. Valente, A. J., D. T. Graves, C. E. Vialle-Valentin, R. Delgado, and C. J. Schwartz. 1988. Purification of a monocyte chemotactic factor secreted by nonhuman primate vascular cells in culture. Biochemistry 27:4162.
7. Allavena, P., G. Bianchi, D. Zhou, J. van Damme, P. Jilek, S. Sozzani, and A. Mantovani. 1994. Induction of natural killer cell migration by monocyte chemotactic protein-1, -2 and -3. Eur. J. Immunol. 24:3233.
8. Carr, M. W., S. J. Roth, E. Luther, S. S. Rose, and T. A. Springer. 1994. Monocyte chemoattractant protein 1 acts as a T-lymphocyte chemoattractant. Proc. Natl. Acad. Sci. USA 91:3652.
9. Yoshimura, T., and E. J. Leonard. 1990. Identification of high affinity receptors for human monocyte chemoattractant protein-1 on human monocytes. J. Immunol. 145: 292.
10. Charo, I. F., S. J. Myers, A. Herman, C. Franci, A. J. Connolly, and S. R. Coughlin. 1994. Molecular cloning and functional expression of two monocyte chemoattractant protein I receptors reveals alternative splicing of the carboxyl-terminal tails. Proc. Natl. Acad. Sci. USA 91:2752.
11. Kurihara, T., G. Warr, J. Loy, and R. Bravo. 1997. Defects in macrophage recruitment and host defense in mice lacking the CCR2 chemokine receptor. J. Exp. Med. 186:1757.
12. Han, K. H., R. K. Tangirala, S. R. Green, and O. Quehenberger. 1998. Chemokine receptor CCR2 expression and monocyte chemoattractant protein-1-mediated chemotaxis in human monocytes: a regulatory role for plasma LDL. Arterioscler. Thromb. Vasc. Biol. 18:1983.
13. Graves, D. T., and A. J. Valente. 1991. Monocyte chemotactic proteins from human tumor cells. Biochem. Pharmacol. 41:333.
14. Desbaillets, I., M. Tada, N. de Tribolet, A. C. Diserens, M. F. Hamou, and E. G. Van Meir. 1994. Human astrocytomas and glioblastomas express monocyte chemoattractant protein-1 (MCP-1) in vivo and in vitro. Int. J. Cancer 58:240.
15. Leung, S. Y., M. P. Wong, L. P. Chung, A. S. Chan, and S. T. Yuen. 1997. Monocyte chemoattractant protein-1 expression and macrophage infiltration in gliomas. Acta Neuropathol. 93:518.
16. Bottazzi, B., F. Colotta, A. Sica, N. Nobili, and A. A. Mantovani. 1990. Chemoattractant expressed in human sarcoma cells (tumor-derived chemotactic factor, TDCF) is identical to monocyte chemoattractant protein-1/monocyte chemotactic and activating factor (MCP-1/MCAF). Int. J. Cancer 45:795.
17. Jiang, Y., A. J. Valente, M. J. Williamson, L. Zhang, and D. T. Graves. 1990. Post-translational modification of a monocyte-specific chemoattractant synthesized by glioma, osteosarcoma, and vascular smooth muscle cells. J. Biol. Chem. 265:18318.
18. Selvan, R. S., J. H. Butterfield, and M. S. Krangel. 1994. Expression of multiple chemokine genes by a human mast cell leukemia. J. Biol. Chem. 269:13893.
19. Isik, F. F., R. P. Rand, J. S. Gruss, D. Benjamin, and C. E. Alpers. 1996. Monocyte chemoattractant protein-1 mRNA expression in hemangiomas and vascular malformations. J. Surg. Res. 61:71.
20. Valkovic, T., K. Lucin, M. Krstulja, R. Dobi-Babic, and N. Jonjic. 1998. Expression of monocyte chemotactic protein-1 in human invasive ductal breast cancer. Pathol. Res. Pract. 194:335.
21. Davidson, B., I. Goldberg, and J. Kopolovic. 1997. Inflammatory response in cervical intraepithelial neoplasia and squamous cell carcinoma of the uterine cervix. Pathol. Res. Pract. 193:491.
22. Conti, P., C. Feliciani, R. C. Barbacane, S. Frydas, F. C. Placido, I. Cataldo, and M. Reale. 1999. Monocyte chemotactic protein-1 gene expression and translation in formed granulomatous calcified tissue in vivo. Calcif. Tissue Int. 64:57.
23. Negus, R. P., G. W. Stamp, M. G. Relf, F. Burke, S. T. Malik, S. Bernasconi, P. Allavena, S. Sozzani, A. Mantovani, and F. R. Balkwill. 1995. The detection and localization of monocyte chemoattractant protein-1 (MCP-1) in human ovarian cancer. J. Clin. Invest. 95:2391.
24. Hall, D. J., C. Brownlee, and C. D. Stiles. 1989. Interleukin-1 is a potent regulator of JE and KC gene expression in quiescent BALB/c fibroblasts. J. Cell. Physiol. 141: 154.
25. Takeshita, A., Y. Chen, A. Watanabe, S. Kitano, and S. Hanazawa. 1995. TGF-β induces expression of monocyte chemoattractant JE/monocyte chemoattractant protein 1 via transcriptional factor AP-1 induced by protein kinase in osteoblastic cells. J. Immunol. 155:419.
26. Rollins, B. J., E. D. Morrison, and C. D. Stiles. 1988. Cloning and expression of JE, a gene inducible by platelet-derived growth factor and whose product has cytokine-like properties. Proc. Natl. Acad. Sci. USA 85:373.
27. Freter, R. R., J. C. Irminger, J. A. Porter, S. D. Jones, and C. D. Stiles. 1992. A novel 7-nucleotide motif located in 3′ untranslated sequences of the immediate-early gene set mediates platelet-derived growth factor induction of the JE gene. Mol. Cell. Biol. 12:5288.
28. Huang, S., R. K. Singh, K. Xie, M. Gutman, K. K. Berry, C. D. Bucana, I. J. Fidler, and M. Bar-Eli. 1994. Expression of the JE/MCP-1 gene suppresses metastatic potential in murine colon carcinoma cells. Cancer Immunol. Immunother. 39:231.
29. Nakashima, E., N. Mukaida, Y. Kubota, K. Kuno, K. Yasumoto, F. Ichimura, I. Nakanishi, M. Miyasaka, and K. Matsushima. 1995. Human MCAF gene transfer enhances the metastatic capacity of a mouse cachectic adenocarcinoma cell line in vivo. Pharm. Res. 12:1598.
30. Rollins, B. J., and M. E. Sunday. 1991. Suppression of tumor formation in vivo by expression of the JE gene in malignant cells. Mol. Cell. Biol. 11:3125.
31. Hirose, K., M. Hakozaki, Y. Nyunoya, Y. Kobayashi, K. Matsushita, T. Takenouchi, A. Mikata, N. Mukaida, and K. Matsushima. 1995. Chemokine gene transfection into tumor cells reduced tumorigenicity in nude mice in association with neutrophilic infiltration. Br. J. Cancer 72:708.
32. Manome, Y., P. Y. Wen, A. Hershowitz, T. Tanaka, B. J. Rollins, D. W. Kufe, and H. A. Fine. 1995. Monocyte chemoattractant protein-1 (MCP-1) gene transduction: an effective tumor vaccine strategy for non-intracranial tumors. Cancer Immunol. Immunother. 41:227.
33. Zhang, L., T. Yoshimura, and D. T. Graves. 1997. Antibody to Mac-1 or monocyte chemoattractant protein-1 inhibits monocyte recruitment and promotes tumor growth. J. Immunol. 158:4855.
34. Zunic, M., G. M. Bahr, G. C. Mudde, J. G. Meingassner, and C. Lam. 1998. MD-P(lysyl)GDP, a nontoxic muramyl dipeptide derivative, inhibits cytokine production by activated macrophages and protects mice from phorbol ester- and oxazolone-induced inflammation. J. Invest. Dermatol. 111:77.
35. Kricek, F., M. Zunic, C. Ruf, G. DeJong, P. Dukor, and G. M. Bahr. 1997. Suppression of in vivo IgE and tissue IL-4 mRNA induction by SDZ 280.636, a synthetic muramyl dipeptide derivative. Immunopharmacology 36:27.
36. Leek, R. D., C. E. Lewis, R. Whitehouse, M. Greenall, J. Clarke, and A. L. Harris. 1996. Association of macrophage infiltration with angiogenesis and prognosis in invasive breast carcinoma. Cancer Res. 56:4625.
37. Brocker, E. B., G. Zwadlo, L. Suter, M. Brune, and C. Sorg. 1987. Infiltration of primary and metastatic melanomas with macrophages of the 25F9-positive phenotype. Cancer Immunol. Immunother. 25:81.
38. Graves, D. T., R. Barnhill, T. Galanopoulos, and H. N. Antoniades. 1992. Expression of monocyte chemotactic protein-1 in human melanoma in vivo. Am. J. Pathol. 140:9.
39. Torisu, H., M. Ono, H. Kiryu, M. Furue, Y. Ohmoto, J. Nakayama, Y. Nishioka, S. Sone, and M. Kuwano. 2000. Macrophage infiltration correlates with tumor stage and angiogensis in human malignant melanoma: possible involvement of TNF-alpha and IL-7-alpha. Int J. Cancer 85:182.
40. Satyamoorthy, K., E. DeJesus, A. J. Linnenbach, B. Kraj, D. L. Kornreich, S. Rendle, D. E. Elder, and M. Herlyn. 1997. Melanoma cell lines from different stages of progression and their biological and molecular analyses. Melanoma Res. 7:35.
41. Herlyn, D., D. Iliopoulos, P. J. Jensen, A. Parmiter, J. Baird, H. Hotta, K. Adachi, A. H. Ross, J. Jambrosic, H. Koprowski, and M. Herlyn. 1990. In vitro properties of human melanoma cells metastatic in nude mice. Cancer Res. 50:2296.
42. Horikawa, T., D. A. Norris, T. Zekman, and J. G. Morelli. 1996. Effective elimination of fibroblasts in cultures of melanocytes by lowering calcium concentration in TPA depleted medium following geneticin treatment. Pigm. Cell. Res. 9:58.
43. Zimrin, A. B., B. Villeponteau, and T. Maciag. 1995. Models of in vitro angiogenesis: endothelial cell differentiation on fibrin but not matrigel is transcriptionally dependent. Biochem. Biophys. Res. Commun. 213:630.
44. Freundlich, B., and N. Avdalovic. 1983. Use of gelatin/plasma coated flasks for isolating human peripheral blood monocytes. J. Immunol. Methods 62:31.
45. Nesbit, M., H. K. Nesbit, J. Bennett, T. Andl, M. Y. Hsu, E. Dejesus, M. McBrian, A. R. Gupta, S. L. Eck, and M. Herlyn. 1999. Basic fibroblast growth factor induces a transformed phenotype in normal human melanocytes. Oncogene 18:6469.
46. D'Andrea, A., M. Aste-Amezaga, N. M. Valiante, X. Ma, M. Kubin, and G. Trinchieri. 1993. Interleukin 10 (IL-10) inhibits human lymphocyte interferon γ-production by suppressing natural killer cell stimulatory factor/IL-12 synthesis in accessory cells. J. Exp. Med. 178:1041.
47. Bottazzi, B., S. Walter, D. Govoni, F. Colotta, and A. Mantovani. 1992. Monocyte chemotactic cytokine gene transfer modulates macrophage infiltration, growth, and susceptibility to IL-2 therapy of a murine melanoma. J. Immunol. 148:1280.
48. Clark, W. H., D. E. Elder, D. Guerry, M. N. Epstein, M. H. Greene, and M. A. Van Horn. 1984. Study of tumor progression: the precursor lesions of superficial spreading and nodular melanoma. Hum. Pathol. 15:1147.
49. Gunn, M. D., N. A. Nelken, X. Liao, and L. Williams. 1997. Monocyte chemoattractant protein-1 is sufficient for the chemotaxis of monocytes and lymphocytes in transgenic mice but requires an additional stimulus for inflammatory activation. J. Immunol. 158:376.
50. Luini, W., S. Sozzani, J. Van Damme, and A. Mantovani. 1994. Species-specificity of monocyte chemotactic protein-1 and -3. Cytokine 6:28.
51. Sunderkoetter, C., K. Steinbrink, M. Goebeler, R. Bhardwaj, and C. Sorg. 1994. Macrophages and angiogenesis. J. Leukocyte Biol. 55:410.
52. Jiang, Y., D. I. Beller, G. Frendl, and D. T. Graves. 1992. Monocyte chemoattractant protein-1 regulates adhesion molecule expression and cytokine production in human monocytes. J. Immunol. 148:2423.
53. Vaddi, K., and R. C. Newton, 1994. Regulation of monocyte integrin expression by β-family chemokines. J. Immunol. 153:4721.
54. Moretti, S., C. Pinzi, A. Spallanzani, E. Berti, A. Chiarugi, S. Mazzoli, M. Fabiani, C. Vallecchi, and M. Herlyn. 1999. Immunohistochemical evidence of cytokine networks during progression of human melanocytic lesions. Int. J. Cancer 84:160.
55. Mattei, S., M. P. Colombo, C. Melani, A. Silvani, G. Parmiani, and M. Herlyn. 1994. Expression of cytokine/growth factors and their receptors in human melanoma and melanocytes. Int. J. Cancer 56:853.
56. Eisengart, C. A., J. R. Mestre, H. A. Naama, P J. Mackrell, D. E. Rivadeneira, E. M. Murphy, P. P. Stapleton, and J. M. Daly. 2000. Prostaglandins regulate melanoma-induced cytokine production in macrophages. Cell. Immunol. 204:143.
57. Netea, M. G., B. J. Kullberg, I. Verschueren, and J. W. Van Der Meer. 2000. Interleukin-18 induces production of proinflammatory cytokines in mice: no intermediate role for the cytokines of the tumor necrosis factor family and the interleukin-1β. Eur. J. Immunol. 30:3057.
58. Lu, C., M. F. Vickers, and R. S. Kerbel. 1992. Interleukin 6: a fibroblast-derived growth inhibitor of human melanoma cells from early but not advanced stages of tumor progression. Proc. Natl. Acad. Sci. USA 89:9215.
59. Goede, V., L. Brogelli, M. Ziche, and H. G. Augustin. 1999. Induction of inflammatory angiogenesis by monocyte chemoattractant protein-1. Int. J. Cancer 82:765.
60. Salcedo, R., M. L. Ponce, H. A. Young, K. Wasserman, J. M. Ward, H. K. Kleinman, J. J. Oppenheim, and W. J. Murphy. 2000. Human endothelial cells express CCR2 and respond to MCP-1: direct role of MCP-1 in angiogenesis and tumor progression. Blood 96:34.
61. Koch, A. E., P. J. Polverini, S. L. Kunkel, L. A. Harlow, L. A. Di Pietro, V. M. Elner, S. G. Elner, and R. M. Strieter. 1992. Interleukin-8 as a macrophage-derived mediator of angiogenesis. Science 258:1798.
62. Ryuto, M., M. Ono, H. Izumi, S. Yoshida, H. A. Welch, K. Kohno, and M. Kuwano. 1996. Induction of vascular endothelial growth factor by tumor necrosis factor-α in human glioma cells: possible role of Sp-1. J. Biol. Chem. 271:28220.
63. Yoshida, S., M. Ono, T. Shono, H. Izumi, T. Ishibashi, H. Suzuki, and M. Kuwano. 1997. Involvement of interleukin-8, vascular endothelial growth factor, and basic fibroblast growth factor in tumor necrosis factor α-dependent angiogenesis. Mol. Cell. Biol. 17:4015.
64. Sato, N., T. Goto, K. Haranaka, N. Satomi, H. Nariuchi, Y. Mano-Hirano, and Y. Sawasaki. 1986. Actions of tumor necrosis factor on vascular endothelial cells: morphologic modulation, growth inhibition, and cytotoxicity. J. Natl. Cancer Inst. 76:1113.
65. Leibovich, S. J., P. J. Polverini, H. M. Shepard, D. M. Wiseman, V. Shively, and N. Nuseir. 1987. Macrophage-induced angiogenesis is mediated by tumour necrosis factor-α. Nature 329:630.
66. Fajardo, L. F., H. H. Kwan, J. Kowalski, S. D. Prionas, and A. C. Allison. 1992. Dual role of tumor necrosis factor-α in angiogenesis. Am. J. Pathol. 140:539.